LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 99 filers reported holding LYELL IMMUNOPHARMA INC in Q1 2023. The put-call ratio across all filers is 3.20 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,682 | -89.0% | 14,750 | -76.2% | 0.00% | – |
| Q2 2023 | $197,392 | -57.7% | 62,073 | -68.6% | 0.00% | – |
| Q1 2023 | $466,239 | +448.5% | 197,559 | +1411.7% | 0.00% | – |
| Q2 2022 | $85,000 | -37.5% | 13,069 | -51.4% | 0.00% | – |
| Q1 2022 | $136,000 | -80.2% | 26,872 | -69.8% | 0.00% | – |
| Q4 2021 | $688,000 | +133.2% | 88,933 | +345.6% | 0.00% | – |
| Q3 2021 | $295,000 | – | 19,960 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $29,638,628 | 28.72% |
| Orland Properties Ltd | 15,093,969 | $22,188,134 | 11.75% |
| Foresite Capital Management IV, LLC | 8,784,813 | $12,913,675 | 7.17% |
| MIC Capital Management UK LLP | 1,740,569 | $2,558,636 | 0.58% |
| Alphabet Inc. | 5,865,125 | $8,621,733 | 0.55% |
| HSG Holding Ltd | 3,045,997 | $4,477,616 | 0.48% |
| Clarius Group, LLC | 399,168 | $586,777 | 0.06% |
| CAXTON ASSOCIATES LP | 198,477 | $291,761 | 0.04% |
| XTX Topco Ltd | 114,720 | $168,638 | 0.03% |
| BBR PARTNERS, LLC | 164,041 | $241,140 | 0.03% |